Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Other Non-Current Liabilities (2023 - 2025)

CG Oncology (CGON) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities changed N/A year-over-year to $1.7 million, compared with a TTM value of $1.7 million through Dec 2025, changed N/A, and an annual FY2025 reading of $1.7 million, changed N/A over the prior year.
  • Other Non-Current Liabilities was $1.7 million for Q4 2025 at CG Oncology, down from $3.8 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $3.8 million in Q3 2025 and bottomed at $365000.0 in Q4 2023.